Volume 13, Issue 4 (12-2025)                   JoMMID 2025, 13(4): 282-290 | Back to browse issues page

Ethics code: Not required as no human subject was involved directly

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jawanpuria A, Asati S, Chaudhary U. Natural Compounds as Novel Biofilm Inhibitors: Targeting Multidrug-Resistant Bacterial Pathogenesis. JoMMID 2025; 13 (4) :282-290
URL: http://jommid.pasteur.ac.ir/article-1-639-en.html
Natural Compounds as Novel Biofilm Inhibitors: Targeting Multidrug-Resistant Bacterial Pathogenesis
Ankita Jawanpuria * , Shruti Asati , Uma Chaudhary
Department of Microbiology, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India
Abstract:   (227 Views)
Introduction: Biofilm formation by multidrug-resistant (MDR) bacteria confers increased antimicrobial tolerance and contributes to persistent infections, presenting significant therapeutic challenges. These challenges have driven research into natural compounds that may target key processes, including efflux pump activity, quorum sensing, bacterial adhesion, and biofilm development. This study investigates the anti-biofilm efficacy of six naturally occurring compounds—berberine, chitosan, curcumin, eugenol, linoleic acid, and reserpine—against clinically relevant aerobic MDR bacterial pathogens. Methods: Biofilm formation was evaluated in 200 MDR clinical isolates, including isolates of Escherichia coli (n=49), Klebsiella pneumoniae (n=46), Acinetobacter baumannii (n=24), Pseudomonas aeruginosa (n=29), Staphylococcus aureus (n=25), and Staphylococcus epidermidis (n=27), sourced from various clinical specimens, including pus, urine, blood, and sputum. Biofilm production was quantified using the modified tissue culture plate (MTCP) method. From these isolates, 36 strong biofilm-forming isolates were selected, and the minimum biofilm inhibitory concentration (MBIC) of each compound was determined via a microtiter plate assay with two-fold serial dilutions. Results: Of 200 isolates, 101 (50.5%) exhibited biofilm formation. MBIC values ranged from 0.0156 mg/mL (lowest for eugenol against E. coli and reserpine against E. coli, K. pneumoniae, and S. aureus) to 1 mg/mL (for curcumin against P. aeruginosa and A. baumannii). Eugenol and reserpine showed significantly lower MBICs compared to curcumin (P < 0.05). Eugenol displayed the lowest mean MBIC (0.049 mg/mL) across the 36 selected strong biofilm-forming isolates, followed by reserpine (0.070 mg/mL), while curcumin exhibited the highest mean MBIC (0.583 mg/mL). Linoleic acid demonstrated its lowest MBIC (0.0312 mg/mL) against K. pneumoniae. Conclusion: The tested compounds exhibited variable anti-biofilm potency, with eugenol and reserpine demonstrating the greatest efficacy and curcumin the least, suggesting limited anti-biofilm efficacy at tested concentrations. These findings underscore the potential of eugenol, reserpine, linoleic acid, berberine, and chitosan as promising in vitro anti-biofilm candidates for managing biofilm-associated infections caused by MDR bacteria; however, in vivo efficacy, pharmacokinetics, and safety warrant further investigation in animal models and clinical trials.
 
Keywords: Anti-biofilm activity, Berberine, Biofilm, Chitosan, Curcumin, Eugenol, Linoleic acid, Multidrug-resistant (MDR) bacteria, Natural compounds, Reserpine
Full-Text [PDF 869 kb]   (92 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2023/12/19 | Accepted: 2025/12/10 | Published: 2026/02/3
attachement [JPG 272 KB]  (10 Download)
References
1. Vani S, Vadakkan K, Mani B. A narrative review on bacterial biofilm: its formation, clinical aspects and inhibition strategies. Future J Pharm Sci. 2023; 9 (1): 50. [DOI:10.1186/s43094-023-00499-9]
2. Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms. 2023; 11 (6): 1614. [DOI:10.3390/microorganisms11061614] [PMID] [PMCID]
3. Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018; 9 (1): 522-54. [DOI:10.1080/21505594.2017.1313372]
4. Magesh H, Kumar A, Alam A, Priyam, Sekar U, Sumantran VN, et al. Identification of natural compounds which inhibit biofilm formation in clinical isolates of Klebsiella pneumoniae. Indian J Exp Biol. 2013; 51 (9): 764-72.
5. Madhusoodhanan A, Minsa M, Mohanan AG, Kumar P. Bacterial biofilm eradication and combating strategies. Asia-Pac J Mol Biol Biotechnol. 2022; 30 (1): 22-36. [DOI:10.35118/apjmbb.2022.030.1.03]
6. Parham S, Kharazi AZ, Bakhsheshi-Rad HR, Nur H, Ismail AF, Sharif S, et al. Antioxidant, antimicrobial and antiviral properties of herbal materials. Antioxidants. 2020; 9 (12): 1309. [DOI:10.3390/antiox9121309] [PMCID]
7. Yadav MK, Chae SW, Im GJ, Chung JW, Song JJ. Eugenol: a phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms. PLoS One. 2015; 10 (3): e0119564. [DOI:10.1371/journal.pone.0119564] [PMID]
8. Chu M, Zhang MB, Liu YC, Kang JR, Chu ZY, Yin KL, et al. Role of berberine in the treatment of methicillin-resistant Staphylococcus aureus infections. Sci Rep. 2016; 6: 24748. [DOI:10.1038/srep24748] [PMID] [PMCID]
9. Etemadi S, Barhaghi MHS, Leylabadlo HE, Memar MY, Mohammadi AB, Ghotaslou R. The synergistic effect of turmeric aqueous extract and chitosan against multidrug-resistant bacteria. New Microbes New Infect. 2021; 41: 100861. [DOI:10.1016/j.nmni.2021.100861] [PMID] [PMCID]
10. Sun T, Li XD, Hong J, Liu C, Zhang XL, Zheng JP, et al. Inhibitory effect of two traditional Chinese medicine monomers, berberine and matrine, on the quorum sensing system of antimicrobial-resistant Escherichia coli. Front Microbiol. 2019; 10: 2584. [DOI:10.3389/fmicb.2019.02584] [PMID] [PMCID]
11. Soni KA, Jesudhasan P, Cepeda M, Widmer K, Jayaprakasha GK, Patil BS, et al. Identification of ground beef-derived fatty acid inhibitors of autoinducer-2-based cell signaling. J Food Prot. 2008; 71 (1): 134-8. [DOI:10.4315/0362-028X-71.1.134]
12. Martinez LR, Mihu MR, Han G, Frases S, Cordero RJB, Casadevall A, et al. The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials. 2010; 31 (4): 669-79. [DOI:10.1016/j.biomaterials.2009.09.087] [PMID] [PMCID]
13. Vetvicka V, Vetvickova J, Fernandez-Botran R. Effects of curcumin on Helicobacter pylori infection. Ann Transl Med. 2016; 4 (24): 479. [DOI:10.21037/atm.2016.12.52]
14. Collee JG, Fraser AG, Marmion BP, Simmons A. Mackie and McCartney practical medical microbiology. 14th ed. New York, NY: Churchill Livingstone; 1996.
15. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 27th ed. CLSI supplement M100. Wayne (PA): CLSI; 2017.
16. Agrawal A, Chaudhary U. Effect of natural compounds on inhibition of biofilm formation of multi drug resistant Staphylococcus aureus and Staphylococcus epidermidis - an in vitro study. Int J Curr Microbiol Appl Sci. 2018; 7 (2): 2921-6. [DOI:10.20546/ijcmas.2018.702.354]
17. Faaz N, Saeed SM, Bnyan IA. Biofilm formation by bacterial isolates from burn infected patients. Med J Babylon. 2012; 9 (3): 517-25.
18. Asati S, Chaudhary U. Prevalence of biofilm producing aerobic bacterial isolates in burn wound infections at a tertiary care hospital in northern India. Ann Burns Fire Disasters. 2017; 30 (1): 39-42.
19. Samant S, Pai C. Evaluation of different detection methods of biofilm formation in clinical isolates of Staphylococci. Int J Pharm Bio Sci. 2012; 3 (4): 724-33.
20. Bala M, Gupte S, Aggarwal P, Kaur M, Manhas A. Biofilm producing multidrug resistant Acinetobacter species from a tertiary care hospital: a therapeutic challenge. Int J Res Med Sci. 2017; 4 (7): 3024-6. [DOI:10.18203/2320-6012.ijrms20161997]
21. Yang D, Zhang Z. Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum beta-lactamases. J Hosp Infect. 2008; 68 (4): 369-71. [DOI:10.1016/j.jhin.2008.02.001] [PMID]
22. Aswathanarayan JB, Vittal RR. Inhibition of biofilm formation and quorum sensing mediated phenotypes by berberine in Pseudomonas aeruginosa and Salmonella typhimurium. RSC Adv. 2018; 8 (63): 36133-41. [DOI:10.1039/C8RA06413J] [PMID] [PMCID]
23. Kim YG, Lee JH, Gwon G, Kim SI, Park JG, Lee J. Essential oils and eugenols inhibit biofilm formation and the virulence of Escherichia coli O157:H7. Sci Rep. 2016; 6: 36377. [DOI:10.1038/srep36377] [PMID]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.